trastuzumab resistant

Related by string. * Trastuzumab : trastuzumab emtansine T DM1 . trastuzumab DM1 T DM1 . compound trastuzumab DM1 . trastuzumab Herceptin ® . trastuzumab DM1 . trastuzumab Herceptin R / RESISTANT . Resistant . resistants : Mine Resistant Ambush Protected . antibiotic resistant bacteria . herbicide resistant weeds . scratch resistant . Extensively Drug Resistant Tuberculosis * *

Related by context. All words. (Click for frequent words.) 69 cisplatin resistant 67 TRAIL induced apoptosis 66 HER2 neu 66 kidney urologic 66 sortilin 66 oncogenic signaling 65 hypermethylated 65 IGF IR 65 experimental autoimmune encephalomyelitis 65 CYT# potent vascular disrupting 65 synovial cells 65 γ secretase 65 MAP kinase 65 NF kB pathway 65 apoptosis induced 65 JAK2 enzyme 64 CDK4 64 SETDB1 64 serine threonine kinase 64 potent antiproliferative 64 synovial fibroblasts 64 potent inducer 64 FGFs 64 receptor inhibitor 64 E#F# 64 nutlin 3a 64 EGF receptor 64 antibody mediated 64 Wnt signaling pathway 64 Ph + acute lymphoblastic 64 HER2 positive cancers 64 alkylating 64 nonmetastatic 64 interleukin IL -# 63 Smac mimetic 63 MAPK pathway 63 Rap1 63 oncogenic transformation 63 LRP5 63 MMP2 63 HER2 positive breast 63 antisense inhibition 63 prostaglandin E2 63 mutated p# 63 GRNOPC1 contains 63 Hypoxia Inducible Factor 63 p# deficient 63 IL 1Ra 63 selectively inhibited 63 NKG2D 63 metastatic colorectal 63 pathophysiological effects 63 Src kinase 63 downregulating 63 beta adrenergic receptors 63 prostate carcinoma 63 ovarian endometrial 63 androgen receptor AR 63 malignant prostate 63 orexin receptors 63 CXCR2 63 IGFBP2 63 inverse agonist 63 lymphomas leukemias 63 autocrine 63 glial tumors 63 5 HT2A receptor 63 enkephalin 63 NF kappaB activation 63 Clusterin 63 methyl D aspartate 62 KRAS oncogene 62 related apoptosis inducing 62 FGFR1 62 microtubule dynamics 62 treating neuropathic pain 62 AT1R 62 hedgehog pathway 62 BRAF gene 62 EGFR protein 62 C5aR 62 Nedd4 62 Fas ligand 62 #HT#A 62 endometrial ovarian 62 NF kB signaling 62 Topoisomerase II 62 Ets2 62 Cathepsin B 62 GPC5 62 cathepsins 62 anti CD3 62 HGS ETR1 mapatumumab 62 microvascular endothelial cells 62 Smac mimetics 62 PHD2 62 FGFR4 62 serine proteases 62 glucocorticoid receptors 62 IAP inhibitor 62 TNFα 62 histone deacetylases 62 imatinib Gleevec 62 cypin 62 ARF1 62 ovarian pancreatic 62 fusion enhancers 62 Notch receptors 62 mTOR mammalian target 62 IGF 1R 62 CXCR4 receptor 62 M1 macrophages 62 Androgen receptor 62 chimeric monoclonal antibody 62 IL 1β 62 eotaxin 62 c MYC 62 antiproliferative effects 62 flavopiridol 62 caveolin 1 62 neurite outgrowth 62 Immunohistochemical analysis 62 leukemia myeloma 62 PKC inhibitors 62 LHRH receptor positive 62 pleiotropic 62 HIF 1α 62 plexiform 62 Src kinases 62 KRAS mutant 62 mutated K ras 61 K ras mutations 61 mGluR5 antagonist 61 FUSILEV enhances 61 RKIP 61 ERBB2 61 TNFa 61 ERK1 2 61 cyclophilin D 61 EGFR tyrosine kinase inhibitors 61 MT1 MMP 61 Leukemias 61 papillary renal cell carcinoma 61 RUNX3 61 EGFR mutation positive 61 EGFr 61 oncomodulin 61 histone deacetylation 61 BRAF protein 61 cyclooxygenase 2 61 lysyl oxidase 61 ERK signaling 61 renal fibrosis 61 tumorigenicity 61 granzyme B 61 neurofibromin 61 Ii protein 61 uPAR 61 N Myc 61 Gleevec resistant 61 pathogenic mechanisms 61 BCR ABL protein 61 NSCLC tumors 61 pancreatic prostate 61 IL 1ß 61 pulmonary metastasis 61 c MET 61 epigenetically 61 hypoxia inducible factor 61 chronic myeloid 61 LPA1 receptor 61 metastatic lymph nodes 61 B7 H4 61 mitogenic 61 NKX#.# 61 synovial tissue 61 molecular abnormalities 61 intracellular signaling pathways 61 erlotinib Tarceva ® 61 costimulatory 61 BRCA deficient 61 EphA2 61 immunotoxin 61 PECAM 1 61 gastric carcinogenesis 61 mitogen activated protein kinases 61 breast carcinomas 61 conventional chemotherapies 61 immuno modulatory 61 VEGF receptor 61 oncoprotein 61 effector function 61 induces apoptosis 61 Upregulation 61 pancreatic colon 61 HER2 overexpression 61 AGTR1 61 SSc 61 blocking cannabinoid receptors 61 adrenoceptor 61 calcineurin 61 HER2 HER2 61 MGd 61 thymidylate synthase 61 upregulating 61 mitogen activated protein kinase 61 hepatoma 61 PARP inhibition 61 acetylcholine receptor 61 Smoothened 61 beta1 integrin 61 thymidylate synthase TS 61 somatostatin 61 IL #R 61 gastrointestinal stromal tumors GISTs 61 cardio metabolic diseases 61 5 HT1A receptor 61 selective inhibition 61 Epstein Barr Virus EBV 61 non mutated KRAS 61 5 lipoxygenase 61 myopathies 61 antiangiogenic therapy 61 Glioblastoma multiforme GBM 61 endocrine therapies 61 ERK pathway 61 SMAD4 61 metastatic melanomas 61 apoptotic pathway 60 PAK1 60 #beta HSD 1 60 lymphangiogenesis 60 antiapoptotic 60 somatostatin receptors 60 NR2B 60 antiestrogen 60 PLX STROKE targeting 60 TGF beta pathway 60 IRAK1 60 BRAF V#E 60 Oncogenic 60 ADAMTS# 60 Angiotensin converting enzyme 60 cholesterol homeostasis 60 serotonin receptor 60 androgen receptors 60 inducible nitric oxide synthase 60 angiogenesis inhibition 60 intracellular protein 60 IGFBP 3 60 colorectal carcinoma 60 xenograft models 60 Valproic acid 60 gastric carcinomas 60 tumor suppressor protein 60 EphB2 60 downregulate 60 Smad3 60 anti inflammatory cytokine 60 iNOS 60 HER2 receptor 60 CaM kinase II 60 mTOR inhibitors 60 MAPK 60 plus dacarbazine 60 chemo resistant 60 VHL gene 60 interferon pathway 60 glutamate receptors 60 ovarian lung 60 CEACAM1 60 Stat5 60 LRAT 60 endogenous opioid 60 selective modulator 60 pro angiogenic 60 pancreatic lung 60 opioid peptides 60 dysregulated 60 Vidaza ® 60 transgenic rats 60 mutated KRAS gene 60 syngeneic 60 FUS1 60 PPARγ 60 RIP1 60 Akt activation 60 lung cancer NSCLC 60 cervical lymph nodes 60 activate p# 60 tryptase 60 immune modulating 60 TXNIP 60 anti fibrotic 60 osteosarcomas 60 guanosine 60 cytokine signaling 60 PKC alpha 60 PDGFR 60 induce apoptosis 60 rifamycins 60 neurokinin 1 60 alpha adrenergic 60 ChR2 60 SPINK1 60 NOD2 60 cordycepin 60 Wnt1 60 vimentin 60 costimulation 60 prostate carcinomas 60 pegylated liposomal doxorubicin 60 GIST tumors 60 SGS# 60 myelofibrosis polycythemia vera 60 Skp2 60 P#X# receptor 60 neurotrophic 60 CD# expressing 60 pancreatic islet beta 60 IFN γ 60 nicotinic acetylcholine receptor 60 CagA 60 receptor molecule 60 TLR3 60 chemokine receptor 60 epithelial tumors 60 ERalpha 60 Epstein Barr virus EBV 60 thalidomide Thalomid 60 beta arrestin 60 Gleevec inhibits 60 aldose reductase 60 RNA silencing 60 enzyme inhibitor 60 TAp# 60 TMEM#B 60 cyclin E 60 HER2 receptors 60 neuronal nitric oxide synthase 60 tumor subtypes 60 neutrophil recruitment 60 STAT3 60 fibrogenesis 60 LDLR 60 Mitomycin C 60 EGFR pathway 60 ErbB receptors 60 C EBP alpha 60 PKCi 60 ectopic expression 60 factor TNF 59 S#P# 59 accumulate preferentially 59 miR #b [002] 59 cAMP signaling 59 mGluR2 NAM 59 TRPV1 receptors 59 apoptosis pathways 59 TGF b 59 protein secreted 59 Hedgehog signaling 59 hormonally sensitive 59 NFkappaB 59 tyrosine kinase inhibitor 59 colorectal tumor 59 miRNA expression 59 cholecystokinin CCK 59 vinca alkaloid 59 COX2 59 transthyretin 59 oligodendrogliomas 59 CDK8 59 immunized mice 59 β catenin 59 ischemia induced 59 inhibiting COX 59 Hedgehog pathway 59 DHFR 59 nonmelanoma skin cancers 59 TRAIL R2 59 radionuclide therapy 59 gemcitabine Gemzar 59 glutamate signaling 59 pDCs 59 triggers apoptosis 59 Enzastaurin 59 neuro endocrine 59 PCNSL 59 immunostimulatory 59 DFMO 59 neural progenitor cells 59 ERa 59 transcriptional activation 59 humanized monoclonal antibodies 59 HLA DR 59 integrin receptor 59 protease activated 59 EGFR receptor 59 PAR1 59 Chronic pancreatitis 59 MMP9 59 TGF beta signaling 59 cytostatic 59 TGF ß 59 adipogenic 59 FLT3 59 PPARg 59 gonadotrophin releasing hormone 59 vitamin D receptors 59 5 HT4 59 MAP kinases 59 experimentally induced 59 VIPR2 59 micro RNAs 59 Papillary 59 microtubule inhibitor 59 topoisomerase 59 FasL 59 pancreatic endocrine 59 PTPN# 59 PIK3CA 59 thioredoxin 59 microRNA molecules 59 muscarinic receptors 59 cannabinoid receptors 59 cyclic AMP cAMP 59 Her2 positive 59 metalloproteinase 59 siRNA knockdown 59 dysplastic lesions caused 59 5 HT6 receptor 59 CCR5 receptors 59 Kinoid 59 M.tb 59 5alpha reductase 59 AEG# 59 alkylating agent 59 HMG CoA reductase 59 Aurora kinase 59 STK# [002] 59 coagulation cascade 59 epithelial tissues 59 GRP# 59 ras oncogene 59 TrkB 59 estrogen receptor alpha 59 MIF protein 59 ovarian carcinoma 59 TGF alpha 59 T#I [002] 59 GBM tumors 59 NFkB 59 hematopoietic cancers 59 LKB1 59 TNFalpha 59 podocyte 59 Angiotensin 59 NF KappaB 59 kinase inhibition 59 colorectal adenocarcinoma 59 cisplatin chemotherapy 59 Bcl2 59 neuropeptide Y NPY 59 inhibit VEGF 59 PTP1B 59 pRb 59 Adjuvant chemotherapy 59 HIF 1a 59 Notch signaling 59 Galectin 59 deacetylation 59 TNF α 59 UCP2 59 radiolabeled TM# 59 p#INK#a 59 TTR amyloidosis 59 anti TNFa 59 estrogen receptors 59 cyclooxygenase 59 potent stimulator 59 neuromuscular junction 59 mutant p# 59 interleukin 1ß 59 mediated apoptosis 59 CB2 receptor 59 HG PIN 59 humoral antibody 59 chemoresistant 59 Systemic lupus erythematosus 59 beta subunit 59 P selectin 59 HCV replication 59 HIF 2alpha 59 lymphoid tumors 59 immunoregulatory 59 TGF β 59 CLL cells 59 EZH2 59 PTEN gene 59 metastatic bladder 59 neuroblastomas 59 IRS1 59 Ribavirin causes 59 p# MAPK 59 immune modulatory 59 treating cancerous tumors 59 lung ovary 59 novel VDA molecule 59 osteoprotegerin OPG 59 intracellular signaling 59 dopamine D1 59 Akt1 59 deCODE BreastCancer 59 cell adhesion molecule 59 induce apoptosis programmed 59 tissue fibrosis 59 nonnucleoside reverse transcriptase inhibitors 59 Cyclin E 59 S#A# [002] 59 fibrin deposition 59 p# mutations 59 vWF 59 sorafenib tablets 59 advanced malignant hepatic 59 Cytotoxic T 59 glutamic acid decarboxylase 59 antiangiogenic 59 induced apoptosis 59 #ß HSD1 59 opiate receptors 59 TNF receptors 59 carcinoma HCC 59 regulates gene expression 59 cardiac fibroblasts 59 cyclin dependent kinases CDKs 59 apoptosis proteins 59 protein kinase C 59 transcriptional regulation 59 PCA3 gene 59 Notch1 59 Oncogenes 59 NOD mice 59 nitric oxide synthase 59 membranous nephritis 59 biologic pathways 59 eIF4E 59 transcriptional repressor 59 posttranslational modification 59 peptide antigens 59 metalloproteinases 59 mineralocorticoid 59 HbF 59 sphingolipid 59 prostate carcinogenesis 58 radiolabeled antibodies 58 amyloid formation 58 pancreatic adenocarcinoma 58 FGFR 58 EGF receptors 58 Locked Nucleic Acid LNA 58 IL #p# 58 Hedgehog signaling pathway 58 adeno associated viruses 58 anti angiogenic drugs 58 recurrent glioblastoma multiforme 58 innate immune responses 58 receptor tyrosine kinase 58 doxorubicin Adriamycin 58 AT1 receptor 58 endogenous cannabinoids 58 Fibroblast 58 autophagic 58 uPA 58 neutralizing antibody responses 58 viral protease 58 Temsirolimus 58 PI3K Akt 58 apoptotic pathways 58 diabetic kidney 58 oncogenic mutations 58 poly ADP ribose polymerase 58 squamous cell lung cancer 58 liver metastasis 58 Nkx#.# 58 LNCaP cells 58 glucocorticoid receptor 58 human airway epithelial 58 osteoblast 58 tumor necrosis 58 ZNF# 58 neurosteroid 58 p# mitogen activated 58 herpesviruses 58 metastatic renal 58 unconjugated 58 Waldenstrom macroglobulinemia 58 HBeAg negative 58 casein kinase 58 radiosensitivity 58 retinoic acid receptor 58 lymphoid cells 58 FGFR3 58 EGFR inhibitors 58 CTAP# Capsules 58 mononuclear 58 P#X# receptors 58 constitutive activation 58 nAChRs 58 nucleoside analogues 58 deCODE ProstateCancer TM 58 proapoptotic 58 busulfan 58 neuronal dysfunction 58 carcinoid 58 IL 1beta 58 C1q 58 PI3K AKT 58 FOLFOX chemotherapy 58 BMP4 58 PGC 1α 58 bleomycin 58 downregulation 58 tumor vascularization 58 gastric carcinoma 58 tenascin C 58 matrix metalloproteinases 58 Rb#/p# 58 treating sarcoma testicular 58 STAT1 58 immune effector 58 trophoblasts 58 LPA1 58 pyridostigmine 58 neuroendocrine cancers 58 NF kappaB 58 Flt3 58 prostaglandin D2 58 HDAC inhibition 58 RRM1 58 prodynorphin 58 genotoxic stress 58 severe hepatic dysfunction 58 leukocyte adhesion 58 mitochondrial toxicity 58 anti angiogenic agents 58 Induced pluripotent stem cells 58 cytokine receptor 58 PDGF receptor 58 chromosomal mutations 58 endogenous ligands 58 factor Xa 58 EGFRvIII 58 B7 H1 58 tumor metastasis 58 tumoral 58 FGFR2 58 CD#c 58 gefitinib Iressa 58 PKM2 58 MEK1 58 breast cancer metastasis 58 taxane chemotherapy administered 58 IGF1R 58 IFNg 58 PI3K/mTOR 58 COX enzymes 58 tumor subtype 58 lung metastasis 58 cytoprotective 58 missense mutations 58 5 HT4 receptor 58 aberrantly activated 58 HuR 58 nNOS 58 alpha#beta# integrin 58 intimal hyperplasia 58 chitinase 58 Glioblastoma Multiforme GBM 58 receptor CXCR4 58 apo E 58 Aldosterone 58 lipid rafts 58 GABA receptor 58 AMPA receptor 58 dopamine transporter DAT 58 ErbB4 58 Angiolix 58 RANK ligand 58 enzyme inhibitors 58 tumor regrowth 58 soluble TNF receptor 58 neuroinflammatory 58 GPIIb IIIa 58 inherited mutations 58 p# pathway 58 IKKß 58 TNF receptor 58 nodal metastasis 58 CDK5 58 TTR gene 58 #ME# 58 immunopathology 58 ErbB2 positive 58 gemcitabine carboplatin 58 B7 H3 58 clade B 58 excitotoxic 58 trastuzumab Herceptin ® 58 palladin 58 PTP 1B 58 glucocorticoid receptor gene 58 GSK3B 58 Darapladib 58 elastase 58 GPR# receptor [001] 58 PDGF alpha receptor 58 EP3 receptor 58 pyrimidines 58 overactivation 58 neuronal cell 58 isotypes 58 complement inhibitor eculizumab 58 ANCA associated 58 metastatic neuroendocrine tumors 58 BRAF V#E mutation 58 leukemic stem cells 58 neural progenitor 58 thyrotropin 58 differentially regulated 58 pituitary adenomas 58 coreceptor 58 neuroblastoma tumors 58 catenin 58 CCR5 co 58 small molecule agonists 58 VEGF receptors 58 transgene expression 58 gene amplification 58 HER2/neu 58 renin angiotensin aldosterone 58 KLF2 58 signaling cascades 58 survivin expression 58 amyloid plaque formation 58 GSTT1 58 VEGF induced 58 androgen dependent 58 isoenzymes 58 nicotinic acetylcholine receptors 58 intercellular communication 58 intracellular proteins 58 oncoproteins 58 epigenetic modification 58 downregulated 58 mu opioid 58 NADPH oxidase 58 demonstrated antitumor activity 58 neuroactive 58 receptor mediated endocytosis 58 paricalcitol 58 primary cilia 58 irreversible inhibitor 58 Treg cell 58 Selective Inhibitor 58 lenalidomide dexamethasone 58 Cyclin D1 58 B Raf 58 habenula 58 skeletal metastases 58 Bcl xL 58 Akt signaling 58 nonsmall cell lung cancer 58 melatonin receptors 58 post herpetic 58 glioblastoma tumor 58 eIF 4E 58 lung fibrosis 58 aneuploid cells 58 Tissue Factor 58 CD#b 58 mutant SOD1 58 VEGF expression 58 Basal cell 58 receptor subtypes 58 adhesion molecule 58 human leukocyte antigens 58 M1 muscarinic 58 HDACs 58 peritoneal carcinomatosis 58 soluble receptor 58 Th1 type 58 astrocytic 58 Cryptococcus neoformans 58 CXCL# 58 EGFR HER2 58 BCL#A 58 seminomas 58 extramedullary 58 PC# cells 58 Vidaza azacitidine 58 activin 58 oncogenesis 58 endocrine glands 58 Akt phosphorylation 58 Neuregulin 1 58 NMDA N 58 microglial activation 57 nonmelanoma 57 Tumour Necrosis Factor 57 inhibiting telomerase 57 neuroprotectant 57 seropositive patients 57 S#K# 57 ornithine decarboxylase 57 breast epithelial cells 57 CYP#B# 57 hormone angiotensin II 57 neuroregenerative 57 androgen hormone 57 STAT3 signaling 57 Hepatocellular Carcinoma HCC 57 fibrate drugs 57 inhibit angiogenesis 57 ligand TRAIL 57 5 HT2B receptor 57 stem cell pluripotency 57 dihydrofolate reductase 57 antisense RNA 57 VEGF inhibitors 57 lateral habenula 57 EP1 receptor 57 phosphate S1P 57 GLI1 57 promoter hypermethylation 57 Six3 57 axonal damage 57 Leydig cell 57 branching morphogenesis 57 adenylate cyclase 57 MDR1 57 cell motility 57 TrkA 57 nicotinic receptor 57 NR#A# 57 melanocyte stimulating hormone 57 CXCL5 57 acadesine 57 PI3K signaling 57 osteoclast formation 57 bortezomib Velcade 57 IGFBP7 57 GATA3 57 Helicobacter pylori H. pylori 57 NFκB 57 transarterial 57 thrombin receptor 57 DNA methyltransferases 57 autoimmune encephalitis 57 EGFR mutant 57 axon guidance 57 Relapsing remitting MS 57 Colon polyps 57 PARP1 57 histone deacetylase 57 ErbB2 57 nasopharyngeal carcinoma NPC 57 erythropoietic 57 metabolic enzymes 57 breast endometrial 57 4 PDE4 enzyme 57 adenosine receptor 57 FKBP# 57 transfusion syndrome 57 Y2 receptor 57 E. faecalis 57 multitargeted 57 MMP# 57 thyroid peroxidase 57 immunomodulatory 57 glutamatergic 57 hypoxic tumor 57 RAS pathway 57 RAS RAF MEK 57 TRPV4 57 57 β1 57 EGFR signaling 57 nicotinic 57 familial ALS 57 JAK kinases 57 PKC beta 57 BRCA1 BRCA2 57 GABA aminotransferase 57 genomic alterations 57 basophils 57 mitogen 57 c Src 57 glioma cells 57 telomerase inhibition 57 recurrent metastatic 57 apoptotic cell 57 peroxisome 57 SATB1 57 bone marrow lymph nodes 57 bone metastasis 57 tamoxifen Nolvadex ® 57 Umbilical cord stem cells 57 Tumor necrosis factor 57 melanoma tumors 57 cytokines IL 57 small molecule tyrosine 57 Notch receptor 57 genetic loci 57 telomerase reverse transcriptase 57 immunodeficient mice 57 Acute myeloid leukemia 57 precancerous condition 57 c myc gene 57 D aspartate NMDA receptor 57 survivin 57 proliferative disorders 57 bladder ovarian 57 anterior pituitary 57 MDM2 57 interleukins 57 TRPV1 receptor 57 basal forebrain 57 clonogenic 57 NK1R 57 neurogenic inflammation 57 recurrent ovarian 57 Her-2/neu 57 renal carcinoma 57 antiinflammatory 57 Fc receptor 57 endothelial activation 57 SMN1 57 plasma kallikrein 57 epithelial cell 57 oncogenic 57 pancreatic carcinoma 57 endostatin 57 triterpenoids 57 neoplastic cells 57 CK2 57 CCL# 57 gene p# 57 endothelin receptor 57 neuropilin 57 adenocarcinomas 57 S. pyogenes 57 Glioblastoma multiforme 57 synaptogenesis 57 COL#A# 57 HER2 expression 57 insulin secreting beta 57 Hurthle cell 57 CB1 receptors 57 kallikrein 57 endoxifen 57 skeletal myoblasts 57 FOXO3a 57 CYP #A# 57 pelvic malignancies 57 Integrins 57 gemcitabine Gemzar ® 57 underlying pathophysiology 57 capillary endothelial cells 57 Dr. Bezprozvanny 57 GPR# [002] 57 bronchial epithelial cells 57 lytic 57 radiation chemoradiation 57 hamartomas 57 HNSCC 57 cirrhosis liver failure 57 TLR9 mediated immune 57 localized prostate 57 renal cell carcinomas 57 neuroblastoma cells 57 Neuropeptide Y 57 myocyte 57 tyrosine kinase 57 humanised antibody 57 Wnt beta catenin 57 Metastatic colorectal cancer 57 CYP#A# enzyme 57 axonal degeneration 57 miR #a [002] 57 methylation patterns 57 FGF receptor 57 malignant phenotype 57 psoriasis Crohn disease 57 DLX5 57 histone deacetylase inhibitors 57 JAK3 57 irinotecan chemotherapy 57 TLR9

Back to home page